Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Entertainment
  • Real Estate
  • Business
  • Technology
  • Artificial Intelligence
  • Health
ncarol.com

Revolutionary Anti-Aging Breakthrough Unveiled: Telomere Technology and Telos95 Offer Promising Results
ncarol.com/10267063

Trending...
  • Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail
  • Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
  • Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
Longevity By Nature Logo
TEMECULA, Calif. - ncarol.com -- 16Revolutionary Anti-Aging Breakthrough Unveiled: Telomere Technology and Telos95 Offer Promising Results

TEMECULA, CA – July 16, 2024 - In a groundbreaking development poised to redefine anti-aging treatments, researchers at the Salk Institute have introduced cutting-edge Telomere Technology alongside Telos95®, a clinically proven anti-aging supplement targeting cellular aging. Telos95® consists of a plant-based blend of highly therapeutic polyphenols naturally isolated from grapevine and organic olive leaf.

Telos95®'s phytochemical compounds fight free radicals, nourishing cells with nutrients that promote telomere and cellular longevity, effectively slowing down the aging process of healthy cells. This supplement not only halts the shortening of telomeres but has been shown to lengthen them, reducing cellular age by an average of 7.43 years in just 6 months.

Abdul Alkayali, Vice President of Sales at Longevity by Nature, explains, "Our clinical studies demonstrate that Telos95® protects telomeres, slows cellular aging, and enhances longevity. By harnessing the power of natural polyphenols, we aim to redefine how we approach aging and age-related illnesses."

More on ncarol.com
  • Kitchen Table Economics: An Invitation to Think Differently
  • Gabby Press Earns High Praise From BookLife For Book About the Dangers of Corporate AI
  • Win a $5,000 VIP Family Experience at the 100th Thanksgiving Day Parade in New York City
  • CB Stuffer Announces Private Sale to Secure Future of Brand Growth
  • The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®

Telomere Technology, in conjunction with Telos95®, offers potential benefits in reducing the need for therapies to treat age-related illnesses such as cancer, cardiovascular problems, eye diseases, and inflammatory conditions. Moreover, Telos95® can be prescribed to insurance customers who have undergone telomere testing, showing promise in stopping or reversing telomere shortening with regular use.

"In our human study," Abdul Alkayali continues, "participants who consumed Telos95® daily experienced significant reductions in their TeloYear Age, demonstrating the supplement's efficacy in promoting cellular health and wellness."

For more information on Telos95® visit Telos95: Telomere Lengthening Anti-Aging Supplement (longevitybynature.biz), and on Telomere Technology, visit Anti-Aging Telomere Tech | Worldhealth.net Anti-Aging News.

Contact
Longevity by Nature
abdul@longevitybynature.biz
8774129888


Source: Longevity by Nature

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Lake Norman Philharmonic Annual Holiday Concert 2026
  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
  • Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
  • New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
  • Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
  • Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
  • The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
  • Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
  • HIRO Ostomy Belt Launch by Richard O'Hamill
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • Lake Norman Philharmonic - Free Holiday Concert
  • S&P 500's 4.4% Plunge: Buy the Dip or Wait? KayeDinero Spotlights TrendSetter
  • Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
_catLbl0 _catLbl1

Popular on ncarol.com

  • Parade of Homes Winners Announced - 265
  • Nious Media Expands Independent Entertainment Network Through Gaming, Music and Digital Storytelling - 200
  • North Carolina Author Carrie Sybert Celebrates Three Published Books - 184
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform - 134
  • Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton - 130
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 126
  • 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST) - 118
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs - 118
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options - 115
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology - 113

Similar on ncarol.com

  • Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute